Similarly, when we compared the counts of methylated insulin promotor cfDNA, there was no significant difference between the PCOS and control groups at baseline (p = 0.94) and follow up (p = 0.50) (Fig. 1b). The gene discussed is INS; the disease is polycystic ovary syndrome.